NCT05859529View on ClinicalTrials.gov

A Pharmacokinetic Study of JS002 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

September 11, 2023

Conditions
Health Volunteer
Interventions
DRUG

JS002

The drug was administered by a single subcutaneous injection

Trial Locations (1)

518112

Shenzhen Third People's Hospital, Shenzhen

All Listed Sponsors
collaborator

Sponsor GmbH

OTHER

lead

Shanghai Junshi Bioscience Co., Ltd.

OTHER

NCT05859529 - A Pharmacokinetic Study of JS002 in Healthy Subjects | Biotech Hunter | Biotech Hunter